AUPN907296A0 - Biocontrol agents for use in treatment of opportunistic infections - Google Patents

Biocontrol agents for use in treatment of opportunistic infections

Info

Publication number
AUPN907296A0
AUPN907296A0 AUPN9072A AUPN907296A AUPN907296A0 AU PN907296 A0 AUPN907296 A0 AU PN907296A0 AU PN9072 A AUPN9072 A AU PN9072A AU PN907296 A AUPN907296 A AU PN907296A AU PN907296 A0 AUPN907296 A0 AU PN907296A0
Authority
AU
Australia
Prior art keywords
treatment
opportunistic infections
biocontrol agents
biocontrol
agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AUPN9072A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Priority to AUPN9072A priority Critical patent/AUPN907296A0/en
Publication of AUPN907296A0 publication Critical patent/AUPN907296A0/en
Priority to AU21451/97A priority patent/AU2145197A/en
Priority to PCT/AU1997/000211 priority patent/WO1997036603A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/125—Casei
AUPN9072A 1996-04-02 1996-04-02 Biocontrol agents for use in treatment of opportunistic infections Abandoned AUPN907296A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
AUPN9072A AUPN907296A0 (en) 1996-04-02 1996-04-02 Biocontrol agents for use in treatment of opportunistic infections
AU21451/97A AU2145197A (en) 1996-04-02 1997-04-02 Biocontrol agents for use in treatment of opportunistic infections
PCT/AU1997/000211 WO1997036603A1 (en) 1996-04-02 1997-04-02 Biocontrol agents for use in treatment of opportunistic infections

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPN9072A AUPN907296A0 (en) 1996-04-02 1996-04-02 Biocontrol agents for use in treatment of opportunistic infections

Publications (1)

Publication Number Publication Date
AUPN907296A0 true AUPN907296A0 (en) 1996-04-26

Family

ID=3793386

Family Applications (1)

Application Number Title Priority Date Filing Date
AUPN9072A Abandoned AUPN907296A0 (en) 1996-04-02 1996-04-02 Biocontrol agents for use in treatment of opportunistic infections

Country Status (2)

Country Link
AU (1) AUPN907296A0 (en)
WO (1) WO1997036603A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1110555A1 (en) 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Antiadhesive agent for the pathogen flora of the skin
EP1296693A4 (en) * 2000-06-19 2005-05-25 Mucoprotec Pty Ltd Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor.
FR2915388B1 (en) 2007-04-27 2010-12-24 Oreal COSMETIC WATER SOLUBLE FILM
FR2924307B1 (en) * 2007-12-04 2010-08-27 Gervais Danone Sa USE OF L. CASEI SSP. PARACASEI AS ANTIFUNGAL
FR2930443B1 (en) 2008-04-29 2010-06-25 Oreal EXTEMPORANE CARE PRODUCT BASED ON MICROORGANISM LYOPHILISATE AND SURFACTANT (S) HLB UP TO 12
JP2016522810A (en) * 2013-04-23 2016-08-04 テラジェン ホールディングス リミテッドＴｅｒｒａｇｅｎ Ｈｏｌｄｉｎｇｓ Ｌｉｍｉｔｅｄ Bacterial strain having antibacterial activity and biological control composition containing the same
CN109310720A (en) 2016-06-13 2019-02-05 株式会社村田制作所 The manufacturing method of antibacterial and antiviral drug, anti-bacteria and anti-virus component and antibacterial and antiviral drug
WO2023073183A1 (en) * 2021-10-28 2023-05-04 Dsm Ip Assets B.V. Bioprotection of dairy products

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55113718A (en) * 1979-02-27 1980-09-02 Yakult Honsha Co Ltd Antitumor agent
DD211945A1 (en) * 1982-12-09 1984-08-01 Inst Getreideverarbeitung METHOD FOR THE PRODUCTION OF TAXED PIGEAS
US4956177A (en) * 1985-11-04 1990-09-11 Microlife Technics, Inc. Method for inhibiting fungi
DE3706303A1 (en) * 1987-02-27 1988-11-17 Duelsen Naturprodukte Gmbh The production of a lactic, long-life bread-beverage having a high nutritional value
CA1320165C (en) * 1987-08-06 1993-07-13 Microlife Technics, Inc. Process for producing novel yeast and mold inhibiting products
IT1227154B (en) * 1988-08-05 1991-03-19 A Tosi Farmaceutici S R L Nova PHARMACEUTICAL COMPOSITIONS FOR GYNECOLOGICAL USE BASED ON LATTOBACILLI
SE469875C (en) * 1991-07-25 1997-02-05 Probi Ab Strain of intestinal colonizing Lactobacillus and composition for prophylaxis or treatment of gastrointestinal infections
GB2261372A (en) * 1991-11-15 1993-05-19 Gregor Reid Lactobacillus and skim milk compositions for prevention of urogenital infection
IT1254210B (en) * 1992-02-10 1995-09-14 Simone Claudio De DIETARY AND / OR PHARMACEUTICAL COMPOSITIONS BASED ON LYOPHILIZED LACTIC BACTERIA, THEIR PREPARATION AND USE
FI92498C (en) * 1992-06-10 1994-11-25 Valio Meijerien New microorganism strain, bacterial preparations containing it and their use for controlling yeast and mold
EP0688169A4 (en) * 1993-03-10 1998-01-28 Commw Scient Ind Res Org Biocontrol agents for use in agriculture

Also Published As

Publication number Publication date
WO1997036603A1 (en) 1997-10-09

Similar Documents

Publication Publication Date Title
AU2663097A (en) Compounds and methods for the selective treatment of cancer and bacterial infections
AU5687896A (en) Use of alpha 1L-agonists in the treatment of incontinence
EP0815838A3 (en) External skin treatment composition
AU4266596A (en) Composition and use
AU4047697A (en) Use of microorganisms for processing bioprosthetic tissue
IL118091A0 (en) Formulations for use in treating pediatric bacterial infections
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU5383498A (en) Human chemokine beta-13
AU2387097A (en) Substituted benzylamines and their use for the treatment of depression
AU1892395A (en) Skin cleansing composition
AUPN907296A0 (en) Biocontrol agents for use in treatment of opportunistic infections
EP1057492B8 (en) Blood-compatible composition and medical device using same
AU2068295A (en) Skin treatment composition
AU2870597A (en) Treatment of liquid
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU4178497A (en) HTm4, methods of treatment and assays, agonists and antagonists
AU3127795A (en) Composition and treatment for baldness
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU2160697A (en) Nsaids in the treatment of pruritus
AUPN024994A0 (en) Assay and peptides for use therein
AU2145197A (en) Biocontrol agents for use in treatment of opportunistic infections
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AUPN208095A0 (en) Biocontrol agents for use in treatment of opportunistic infections
AU3103097A (en) Compositions and methods for the treatment of chronic infections